Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...

Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

Dr Verma said: “Your appetite for certain foods or tastes is very likely to change. If patients who are using Ozempic (or any ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

The European Commission has given the fast-fashion retailer one month to rectify practices the bloc believes could be ...

That is the kind of half-joking question that doctors kick around when a new class of drugs begins to help a big chunk of the ...

It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy.

If fillers are about retaining youth, Ozempic is about nailing the metabolism — with needles doing the heavy lifting ...

OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

In this week's newsletter, also read about why Indian pharma companies are fast-tracking alternatives to weight-loss ...